- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Acorda Therapeutics Inc+ Add to Watchlist
ACOR:US40.3500 USD 1.8800 4.89%
As of 20:10:00 ET on 12/18/2014.
Company Profile for Acorda Therapeutics Inc (ACOR)
Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.
Acorda Therapeutics Inc
Key Executives for Acorda Therapeutics Inc (ACOR)
|Ron CohenPresident/CEO/Founder||Michael W RogersChief Financial Officer|
|Andrew HindmanChief Business Development Ofcr||Enrique J CarrazanaChief Medical Officer|
|Andrew R Blight "Andy"Chief Scientific Officer||David LawrenceChief:Business Operations|
|Jane WasmanPres:Intl/Secy/Gen Cnsl||Lauren M SabellaExec VP:Commercial Dev|
|Jeff MacdonaldSenior Dir:Investor Relations|